Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer

European Journal of Cancer

Volumn 36, Issue 10, 2000, Pages 1200-1208

  Anton Culver, H ^a   Cohen, P P ^a   Gildea, M E ^a   Ziogas, A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BRCA1; Breast cancer; Ovarian cancer; Population based

Indexed keywords

BRCA1 PROTEIN;

ADULT; AGE; AGED; BREAST CANCER; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; ETHNOLOGY; FAMILY HISTORY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; OVARY CANCER; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; RACE; WESTERN HEMISPHERE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PEDIGREE; RISK FACTORS;

EID: 0034123318     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00110-6     Document Type: Conference Paper

References (30)

1. American Cancer Society. Cancer Facts and Figures - 1997. Atlanta, GA, American Cancer Society, 1997.
2. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 1991, 48, 232-242.
3. Børresen AL. Role of genetic factors in breast cancer susceptibility. Acta Oncol 1992, 31, 151-155.
4. Easton DF, Bishop DT, Ford D, Crockford GP, Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993, 52, 678-701.
5. Easton DF, Ford D, Bishop DT, Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995, 56, 265-271.
6. Rebbeck TR, Couch FJ, Kant J, et al. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am J Hum Genet 1996, 59, 547-553.
7. Narod SA, Goldgar D, Cannon-Albright L, et al. Risk modifiers in carriers of BRCA1 mutations. In t J Cancer 1995, 64, 394-398.
8. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998, 62, 676-689.
9. Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, King MC. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 1998, 279, 915-921.
10. Fodor FH, Weston A, Bleiweiss IJ, et al. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am J Hum Genet 1998, 63, 45-51.
11. Hamann U, Haner M, Stosiek U, Basiert G, Scott RJ. Low frequency of BRCA1 germline mutations in 45 German breast/ ovarian cancer families. J Med Genet 1997, 34, 884-888.
12. Hakansson S, Johannsson O, Johansson U, et al. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet 1997, 60, 1068-1078.
13. Couch FJ, DeShano ML, Blackwood MA, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997, 336, 1409-1415.
14. Whittemore AS, Gong G, Intyre J. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet 1997, 60, 496-504.
15. Southey MC, Tesoriero AA, Andersen CR, et al. BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer. Br J Cancer 1999, 79, 34-39.
16. Anton-Culver H, Culver BD, Kurosaki T, Osann KE, Lee JB. Incidence of lung cancer by histological type from a populationbased registry. Cancer Res 1988, 48, 6580-6583.
17. Seiffert JE, Price WT, Gordon B. The California tumor registry: a state-of-the-art model for a regionalized, automated, populationbased registry. Top Health Rec Manag 1990, 11, 59-73.
18. Gordon B, ed. Standards for Cancer Registries. Vol I, Data Exchange Standards and Record Description. Sacramento, CA, North American Association of Central Cancer Registries, 1994.
19. Seiffert J, ed. Standards for Cancer Registries. Vol II, Data Standards and Data Dictionary. Sacramento, CA, North American Association of Central Cancer Registries, 1997.
20. Seiffert J, ed. Standards for Cancer Registries. Vol III, Standards for Completeness, Quality, Analysis, and Management of Data. Sacramento, CA, North American Association of Central Cancer Registries, 1997.
21. Anton-Culver H, Kurosaki T, Taylor TH, Gildea M, Brunner D, Bringman D. Validation of family history of breast cancer and identification of the BRCA1 and other syndromes using a populationbased cancer registry. Genet Epidemiol 1996, 13, 193-205.
22. Ziogas A, Gildea M, Cohen P, et al. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiol Biomark Prev 2000, 9, 103-111.
23. Barker DF, Almeida ER, Casey G, et al. BRCA1 R841W: a strong candidate for a common mutation with moderate phenotype. Genet Epidemiol 1996, 13, 595-604.
24. Janezic SA, Ziogas A, Krumroy LM, et al. Germline BRCA1 alterations in a population-based series of ovarian cancer cases. Hum Molec Genet 1999, 8, 889-897.
25. Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV, Ostrander EA. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 with first-degree family history. JAMA 1998, 12, 922-929.
26. Beller U, Halle D, Catane R, Kaufman B, Hornreich G, LevyLahad E. High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history. Gyneco Oncol 1997, 67, 123-126.
27. Levy-Lahad E, Catane R, Eisenberg S, et al. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet 1997, 60, 1059-1067.
28. Mefford HC, Baumbach L, Panguluri RC, et al. Evidence for BRCA1 founder mutation in families of West African ancestry. Am J Hum Genet 1999, 65, 575-578.
29. Gao Q, Neuhausen S, Cummings S, Luce M, Olopade OI. Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. Am J Hum Genet 1997, 60, 1233-1236.
30. Menczer J, Theodor L, Friedman E. BRCA1 185delAG mutation in a non-Ashkenazi Jewish woman with early-onset breast and ovarian cancer. Am J Ob Gyn 1997, 176, 731.